Evidence map›Paper›PMID 32409697›Full record

ArticleNature communications2020

Mitochondrial uncoupler BAM15 reverses diet-induced obesity and insulin resistance in mice.

Stephanie J Alexopoulos, Sing-Young Chen, Amanda E Brandon, Joseph M Salamoun, Frances L Byrne, Christopher J Garcia, Martina Beretta, Ellen M Olzomer, Divya P Shah, Ashleigh M Philp and 12 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed, 1 pooled it
9.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 1 synthesis or guideline pooled it, 131 citations in OpenAlex.

  1. Pooled it
  2. Small Molecule Insulin Sensitisers: New Leads and Targets for Next-Generation Insulin Sensitising Strategies.Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Adipocyte Browning: A Promising Avenue in Anti-Obesity Therapy.International journal of molecular sciences · 2026
    Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Mild Mitochondrial Uncoupling for True Ectopic Lipid Disposal.International journal of molecular sciences · 2025
    Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 7 institutions in 3 countries.

Stephanie J AlexopoulosSchool of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW, 2052, Australia.
Sing-Young ChenSchool of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW, 2052, Australia.ORCID http://orcid.org/0000-0001-5258-8254
Amanda E BrandonSydney Medical School, Charles Perkins Centre, University of Sydney, Sydney, NSW, 2006, Australia.
Joseph M SalamounDepartment of Chemistry and Virginia Tech Centre for Drug Discovery, Virginia Tech, Blacksburg, VA, 24061, USA.
Frances L ByrneSchool of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW, 2052, Australia.ORCID http://orcid.org/0000-0002-8897-8438
Christopher J GarciaDepartment of Chemistry and Virginia Tech Centre for Drug Discovery, Virginia Tech, Blacksburg, VA, 24061, USA.
Martina BerettaSchool of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW, 2052, Australia.
Ellen M OlzomerSchool of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW, 2052, Australia.
Divya P ShahSchool of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW, 2052, Australia.
Ashleigh M PhilpGarvan Institute of Medical Research, Darlinghurst, NSW, Australia.
Stefan R HargettDepartment of Pharmacology, University of Virginia, Charlottesville, VA, 22908, USA.
Robert T LawrenceDepartment of Pharmacology, University of Virginia, Charlottesville, VA, 22908, USA.ORCID http://orcid.org/0000-0002-1031-7373
Brendan LeeBiological Resources Imaging Laboratory, University of New South Wales, Sydney, NSW, 2052, Australia.ORCID http://orcid.org/0000-0002-0347-2105
James SligarGarvan Institute of Medical Research, Darlinghurst, NSW, Australia.
Pascal CarriveDepartment of Anatomy, School of Medical Sciences, University of New South Wales, Sydney, NSW, 2052, Australia.
Simon P TuckerContinuum Biosciences Pty Ltd., Sydney, NSW, 2035, Australia.
Andrew PhilpGarvan Institute of Medical Research, Darlinghurst, NSW, Australia.ORCID http://orcid.org/0000-0003-3860-4136
Carolin LacknerInstitute of Pathology, Medical University of Graz, Graz, Austria.
Nigel TurnerDepartment of Pharmacology, School of Medical Science, University of New South Wales, Sydney, NSW, 2052, Australia.
Gregory J CooneySydney Medical School, Charles Perkins Centre, University of Sydney, Sydney, NSW, 2006, Australia.
Webster L SantosDepartment of Chemistry and Virginia Tech Centre for Drug Discovery, Virginia Tech, Blacksburg, VA, 24061, USA. santosw@vt.edu.ORCID http://orcid.org/0000-0002-4731-8548
Kyle L HoehnSchool of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW, 2052, Australia. k.hoehn@unsw.edu.au.ORCID http://orcid.org/0000-0002-0214-3238
UNSW Sydney · AUGarvan Institute of Medical Research · AUThe University of Sydney · AUUniversity of Virginia · USVirginia Tech · USAgriBio · AUMedical University of Graz · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Obesity is a health problem affecting more than 40% of US adults and 13% of the global population. Anti-obesity treatments including diet, exercise, surgery and pharmacotherapies have so far failed to reverse obesity incidence. Herein, we target obesity with a pharmacotherapeutic approach that decreases caloric efficiency by mitochondrial uncoupling. We show that a recently identified mitochondrial uncoupler BAM15 is orally bioavailable, increases nutrient oxidation, and decreases body fat mass without altering food intake, lean body mass, body temperature, or biochemical and haematological markers of toxicity. BAM15 decreases hepatic fat, decreases inflammatory lipids, and has strong antioxidant effects. Hyperinsulinemic-euglycemic clamp studies show that BAM15 improves insulin sensitivity in multiple tissue types. Collectively, these data demonstrate that pharmacologic mitochondrial uncoupling with BAM15 has powerful anti-obesity and insulin sensitizing effects without compromising lean mass or affecting food intake.

Indexed as

Insulin ResistanceAdipose TissueAdministration, OralAnimalsBlood GlucoseBody TemperatureBody WeightDiaminesDiet, WesternDisease Models, AnimalDose-Response Relationship, DrugGlucose Clamp TechniqueHumansLiverMaleMembrane Potential, MitochondrialBlood GlucoseDiaminesmitochondrial uncoupler BAM15OxadiazolesPyrazines

Identifiers

PMID32409697
PMCPMC7224297
OpenAlexW3024383047

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.